Working… Menu

Safety and Effect of GL-ONC1 Administered IV Prior to Surgery to Patients With Solid Organ Cancers Undergoing Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02714374
Recruitment Status : Active, not recruiting
First Posted : March 21, 2016
Last Update Posted : June 27, 2017
Genelux Corporation
Information provided by (Responsible Party):
Kaitlyn Kelly, MD, University of California, San Diego

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : March 2019
Estimated Study Completion Date : March 2021